The association of hemoglobin a1c with incident heart failure among people without diabetes: the Atherosclerosis Risk in Communities Study

Matsushita, Kunihiro, Blecker, Saul, Pazin-Filho, Antonio, Bertoni, Alain, Chang, Patricia P., Coresh, Josef, Selvin, Elizabeth·2010·Diabetes

Cited by (184)

Items 101–184 of 184

  1. Can Cardiovascular Epidemiology and Clinical Trials Close the Risk Management Gap Between Diabetes and Prediabetes?
    Leigh Perreault, Kristine Færch, Edward W. Gregg · 2017 · Current Diabetes Reports
  2. Do We Need A Wider Therapeutic Paradigm For Heart Failure With Comorbidities?: A Remote Australian Perspective
    Pupalan Iyngkaran, Merlin C. Thomas · 2016 · Health Care Current Reviews
  3. The Role of Bile Acid Sequestrants in the Management of Type 2 Diabetes Mellitus
    Om P. Ganda · 2010 · Metabolic Syndrome and Related Disorders
  4. New Drugs and Devices in the Pipeline for Heart Failure with Reduced Ejection Fraction Versus Heart Failure with Preserved Ejection Fraction
    Amresh Raina, Manreet Kaur Kanwar · 2014 · Current Heart Failure Reports
  5. Diabetes in Native Populations and Underserved Communities in the USA
    Joshua J. Joseph, Sherita Hill Golden · 2016 · Springer eBooks
  6. Stage A Heart Failure
    Pompilio Massimo Faggiano, Nicola Bernardi, Emiliano Calvi, Andrea Bonelli, Andrea Faggiano, Francesca Bursi, Marco Bosisio · 2021 · Heart Failure Clinics
  7. La HbA1c en el diagnóstico y en el manejo de la diabetes
    Germán Campuzano‐Maya, Guillermo Latorre Sierra · 2010 · Dialnet (Universidad de la Rioja)
  8. Glycated Hemoglobin and Outcomes of Heart Failure (from Get With the Guidelines-Heart Failure)
    Justin Basile Echouffo-Tcheugui, Shubin Sheng, Adam D. DeVore, Roland Matsouaka, Adrian F. Hernandez, Clyde W. Yancy, Paul A. Heidenreich, Deepak L. Bhatt, Gregg C. Fonarow · 2018 · The American Journal of Cardiology
  9. A conundrum addressed: the prognostic value of HbA1c
    Elizabeth Selvin, Frederick L. Brancati · 2010 · Nature Reviews Endocrinology
  10. Effects of Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes Mellitus in Open-Label, Marker-Stratified Randomized, Parallel-Group Comparison, Standard Treatment-Controlled Multicenter Trial (TOPLEVEL Study): Rationale and Study Design
    On behalf of the TOPLEVEL investigators and study coordinators, Miki Imazu, Atsushi Nakano, Shin Ito, Toshimitsu Hamasaki, Masafumi Kitakaze · 2019 · Cardiovascular Drugs and Therapy
  11. Identification and correction for collider bias in a genome-wide association study of diabetes-related heart failure
    Yan V. Sun, Chang Liu, Qin Hui, Jin J. Zhou, J. Michael Gaziano, Peter W.F. Wilson, the Million Veteran Program, Lawrence S. Phillips, Lawrence S. Phillips · 2024 · The American Journal of Human Genetics
  12. Evaluation of Patients with Heart Failure
    Maria Patarroyo‐Aponte, Monica M Colvin · 2013 · Cardiology Clinics
  13. Application and Extension of Weighted Quantile Sum Regression for the Development of a Clinical Risk Prediction Tool
    Ghalib Bello · 2014 · VCU Scholars Compass (Virginia Commonwealth University)
  14. Type 2 diabetes, heart failure and the treatment of their comorbidity
    Si Wang, Sheyu Li · 2024 · Minerva Medica
  15. Incorporating Common Biomarkers into the Clinical Management of Heart Failure
    Meghana G. Halkar, W.H. Wilson Tang · 2013 · Current Heart Failure Reports
  16. Dysglycemia and incident heart failure among blacks: The jackson heart study
    Justin Basile Echouffo-Tcheugui, Stanford E. Mwasongwe, Solomon K. Musani, Michael E. Hall, Adolfo Correa, Adrian F. Hernandez, Sherita Hill Golden, Robert John Mentz, Alain Gerald Bertoni · 2021 · American Heart Journal
  17. Cardiovascular Outcomes Trials of Glucose-Lowering Drugs or Strategies in Type 2 Diabetes
    Hertzel C. Gerstein, Reema Shah · 2017 · Endocrinology and Metabolism Clinics of North America
  18. Evaluation of the longitudinal deformation of the left ventricular myocardium in subjects with impaired fasting glucose with and without increased glycated hemoglobin
    Niloofar Akhavan‐Khaleghi · 2018 · The Anatolian Journal of Cardiology
  19. Type 2 diabetes mediated heart failure: focus on early recognition and clinical strategies
    Xi Chen, Wei Shan Li, Jun-Wei Zheng, Meinv Huang, Jinxi Wang, Meifang Wu · 2025 · Frontiers in Endocrinology
  20. The importance of managing diabetes correctly to prevent heart failure
    Filippos K. Triposkiadis, Grigorios Giamouzis, Javed Butler · 2011 · Expert Review of Cardiovascular Therapy
  21. A Diabetes-Associated Genetic Variant is Associated with Diastolic Dysfunction and Cardiovascular Disease
    John Molvin, Amra Jujić, Peter M. Nilsson, Margrét Leósdóttir, Ulf Lindblad, Bledar Daka, Louise Bennet, Lennart Råstam, Valeriya Lyssenko, Martin Magnusson · 2019 · ESC Heart Failure
  22. Comorbidity Patterns in Patients at Cardiovascular Hospital Admission
    Cezara-Andreea Soysaler, Cătălina Liliana Andrei, Octavian Ceban, Crina Julieta Sinescu · 2023 · Medicines
  23. Screening, identification, and management of prediabetes to reduce cardiovascular risk: A missed opportunity?
    Dave L. Dixon, Salvatore Carbone · 2020 · Diabetes/Metabolism Research and Reviews
  24. Influence of Erythropoiesis-Stimulating Agents on Glycated Hemoglobin in Nondiabetic Kidney Diseases at the Start of Dialysis
    Antonio Carlos Cordeiro, Juan Jesús Carrero, Peter F. Barany, Abdul Rashid Qureshi, Olof Heimbürger, Bengt Lindholm, Peter Stenvinkel · 2010 · American Journal of Nephrology
  25. Impact of diabetic status and contribution of office and home blood pressure across diabetic status for cardiovascular disease: the J-HOP study
    Daisuke Suzuki, Satoshi Hoshide, Kazuomi Kario · 2023 · Hypertension Research
  26. Inhibition of the Renin–Angiotensin System Improves Hemodynamic Function of the Diabetic Rat Heart by Restoring Intracellular Calcium Regulation
    Krisztina Anna Paulik, Tamás Ivanics, Gábor Artúr Dunay, Ágnes Fülöp, Margit Kerék, Klára Takács, Zoltán Benyó, Zsuzsanna Miklós · 2025 · Biomedicines
  27. Hemoglobin A1c as a marker for identifying diabetes and cardiovascular risk factors: the China Health and Nutrition Survey 2009
    Xingxing Sun, Tingting Du, Rui Huo, Lixian Xu · 2013 · Acta Diabetologica
  28. Detecting Type 2 diabetes and impaired glucose regulation using glycated hemoglobin in different populations
    Samiul A Mostafa, Kamlesh Khunti, Balasubramanian Thiagarajan Srinivasan, David R. Webb, Melanie Jane Davies · 2011 · Diabetes Management
  29. Age is the main determinant of glycated hemoglobin levels in a general Polish population without diabetes: The NATPOL 2011 Study
    Bartosz Symonides, Bogdan Solnica, Grzegorz Placha, Ewa Pędzich, Marcin Rutkowski, Piotr Bandosz, Zbigniew A. Gaciong, Tomasz Roman Zdrojewski · 2019 · Advances in Clinical and Experimental Medicine
  30. Long-term glycemic variability predicts compromised development of heart failure with improved ejection fraction: a cohort study
    Chen Die Yang, Jia Wei Chen, Jin Wei Quan, Xin Yi Shu, Shuo Feng, Muladili Aihemaiti, Feng Hua Ding, Wei Feng Shen, Lin Lu, Ruiyan Zhang et al. · 2023 · Frontiers in Endocrinology
  31. Midlife determinants of healthy cardiovascular aging: The Atherosclerosis Risk in Communities (ARIC) study
    Xiaoming Jia, Caroline Sun, Vijay Nambi, Salim S. Virani, George E. Taffet, Eric Boerwinkle, Jan Bressler, Chiadi E. Ndumele, Beverly Gwen Windham, James A. de Lemos et al. · 2022 · Atherosclerosis
  32. Diagnose, Prävention und Behandlung kardiovaskulärer Ereignisse bei Menschen mit Diabetes und Prädiabetes
    Konstantinos C. Koskinas, Andreas Melmer, Nicole Steiner, Andreas Gübeli, Matthias Wilhelm, Markus Wolfgang Laimer · 2021 · Praxis
  33. Multi-system trajectories and the incidence of heart failure in the Framingham Offspring Study
    Cara Guardino, Stephanie Pan, Ramachandran Srini Vasan, Vanessa Xanthakis · 2022 · PLoS ONE
  34. Study on the Features of Coronary Artery Atheromatous Plaque for Patients with Impaired Glucose Tolerance when Applying Intravascular Ultrasound
    Jin-Ming Cen, Qingyuan Xiong · 2016 · Cardiovascular Pharmacology Open Access
  35. Study of the features of coronary artery atheromatous plaque using intravascular ultrasound in patients with impaired glucose tolerance
    Jin-Ming Cen, Xi-li Yang, Qingyuan Xiong, Zhaoyan Xu, Ri-Ming Liang · 2016 · Chronic Diseases and Translational Medicine
  36. Cardiovascular Disease Prevention in Women
    Anum Saeed, Martha Gulati · 2020 · Contemporary cardiology
  37. Effect of HemoglobinA1C on the coronary flow velocity after percutaneous coronary intervention
    Zhengbin Wang, Chung-Guang Qiu, Shoujun Wang, Zhanying Han, Zhen-Wen Huang, Guoju Sun · 2015 · Biomedical Research-tokyo
  38. Diabetic Cardiomyopathy and Oxidative Stress
    Somasundaram Arumugam, Vengadeshprabhu Karuppagounder, Rajarajan A. Thandavarayan, Vigneshwaran Pitchaimani, Hirohito Sone, Kenichi Watanabe · 2013 · Elsevier eBooks
  39. Effects of Glucose Lowering Drugs on Cardiovascular Risk in Type 2 Diabetes Mellitus: Realities and Perspectives
    Zhanna D. Kobalava, Gayrat Kiyakbaev · 2018 · Kardiologiia
  40. Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study
    Junichi Ishigami, Ron Cornelis Hoogeveen, Christie Mitchell Ballantyne, Aaron R. Folsom, Josef Coresh, Elizabeth Selvin, Kunihiro Matsushita · 2019 · American Journal of Epidemiology
  41. Dietary and Nutritional Recommendations for the Prevention and Treatment of Heart Failure
    Prerana M. Bhatia, Nicholas W. Wettersten · 2021 · Contemporary cardiology
  42. Role of sodium glucose co-transporter 2 inhibitors in patients with heart failure: an elusive mechanism
    Hafiz M. Imran, William A. Nester, Islam Y. Elgendy, Marwan S Saad · 2020 · Annals of Medicine
  43. Predictive Factors on the Incidence of Heart Failure in Patients with Ischemic Heart Disease: Using a 10-Year Population-Based Korea National Health Insurance Cohort Data
    Seon Young Hwang, Kyung-Ae Kim, Oh Jong Choi · 2020 · International Journal of Environmental Research and Public Health
  44. Impact of glycemic status on left ventricular systolic function in patients with acute coronary syndrome
    Alaaeldin Amin, Waleed Ammar, Azza A.M. Farrag · 2015 · The Ulutaş medical journal/The ulutas medical journal
  45. Translating “Nondiabetic” A1C Levels to Clinical Practice
    William T. Cefalu · 2010 · Diabetes
  46. A multifaceted approach for management of prediabetes and its associated cardiovascular risk
    Mahmoud Al Rifai, Michael David Shapiro · 2020 · Diabetes/Metabolism Research and Reviews
  47. Prevention of Heart Failure
    Richard Brandon Stacey, Douglas D. Schocken · 2020 · Contemporary cardiology
  48. Diabetes and cardiovascular disease
    Carlos Guamán, William Salazar Acosta, Carla Alvarez, Benhard Hasbum · 2023 · Cardiac and Cardiovascular Research
  49. Is Subclinical Myocardial Injury the Smoking Gun Linking Obesity With Heart Failure?
    James A. de Lemos, Ian J. Neeland · 2014 · JACC Heart Failure
  50. Left Ventricular Systolic Function in Asymptomatic Men Aged 65–75 Years, Relation to Insulin Resistance and Pre-Diabetes: A DANCAVAS Cross-Sectional Sub-Study
    Johanna Larsson, Søren Auscher, Freja Sønder Madsen, Katrine Schultz Overgaard, Gokulan Pararajasingam, Laurits Juhl Heinsen, Thomas Rueskov Andersen, Jes Sanddal Lindholt, Jess Lambrechtsen, Kenneth Egstrup · 2025 · Journal of Cardiovascular Development and Disease
  51. The prognostic value of serum Mg2+ concentration in patients with heart failure and type 2 diabetes mellitus: a retrospective cohort study
    Yangyang Jiang, Jingshu Zhang, Zhichao Jiang, Xiaoyu Liu, Lixin Wang · 2025 · Endocrine
  52. Glucose Disposal Rate: A Novel Measure of Insulin Resistance Associated With Myocardial Fibrosis and Incident Heart Failure
    Syed Bukhari, Yaa Adoma Kwapong, Lisa R. Yanek, Erin D. Michos, João A.C. Lima, Wendy S. Post, Cynthia C. Taub, Kavita Sharma, Monica Mukherjee, Benjamin H. Freed et al. · 2026 · Journal of the American Heart Association
  53. Association between right heart catheterization hemodynamics and glycosylated hemoglobin levels in adults with heart failure with reduced ejection fraction
    Gaspar Del Rio‐Pertuz, Cristina Morataya, Kanak Parmar, Zeyad Elharabi, Daniel P. Davis, Mostafa Abohelwa, Ozman J. Ochoa, Alison Tran, KENNETH M. NUGENT, David E. Paniagua et al. · 2023 · Cardiovascular Endocrinology & Metabolism
  54. Study of electrocardiogram parameters in rats in the sucrose model of metabolic syndrome
    Yu. A. Filippov, A V Stepanov, Olga Yu. Karnishkina, А. А. Панов, Oxana V. Chistyakova, Maxim G. Dobretsov · 2025 · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук
  55. Glycated hemoglobin as a long-term predictor of cardiovascular outcomes in patients undergoing carotid endarterectomy
    Raquel Pinheiro-Silva, André Costa Ferreira, Luís Orelhas, Lara Romana-Dias, Hugo C. Ribeiro, João P. Rocha-Neves · 2026 · Acta chirurgica Belgica
  56. Kardiovaskuläre Erkrankungen und Herzinsuffizienz bei Diabetes: Diagnostik und Management (Update 2026)
    Matthias Wolfgang Heinzl, Michael Resl, Julian Maier, Clemens Steinwender, Jürgen Falkensammer, Paul Fellinger, Thomas Steinmaurer, Christoph H. Saely, Friedrich Hoppichler, Harald Stingl et al. · 2026 · Wiener klinische Wochenschrift
  57. Comment on: Matsushita et al. (2010) The Association of Hemoglobin A1c With Incident Heart Failure Among People Without Diabetes: The Atherosclerosis Risk in Communities Study. Diabetes;59:2020–2026
    Eiji Oda · 2010 · Diabetes
  58. Heart Failure (Stages A, B and C)
    Dan D. Le, Trong Ha Le, Võ Minh Viêt, Bao V. Ho, Tuan Duc Nguyen, Khalid Numan Al Azza, Hau Van Tran, Gianluca Rigatelli · 2016 · Wiley eBooks
  59. Comparing Traditional and Newer Definitions of Obesity in Relation to Incident Cardiovascular Disease and Obesity-Related Cancer Risk: A Prospective Cohort Study in ARIC
    Omar Mohamed Makram, Viraj Shah, Tarek Nahle, Xiaoling Wang, Ryan Alan Harris, Steven Scott Coughlin, Neal L. Weintraub, Corinne E. Joshu, Elizabeth A. Platz, Avirup Guha · 2025 · medRxiv
  60. Diabetes mellitus und Herzinsuffizienz
    Roman Pfister, Christian Alfons Schneider · 2011 · Der Diabetologe
  61. Response to Comment on: Matsushita et al. (2010) The Association of Hemoglobin A1c With Incident Heart Failure Among People Without Diabetes: The Atherosclerosis Risk in Communities Study. Diabetes;59:2020–2026
    Kunihiro Matsushita, Elizabeth Selvin · 2010 · Diabetes
  62. Disease Prevention in Heart Failure
    Viorel G. Florea, Jay N. Cohn · 2010 · Elsevier eBooks
  63. Estudio del perfil clínico y biológico de la insuficiencia cardiaca congestiva crónica en relación con el tipo de disfunción ventricular. Análisis del valor pronóstico de las distintas variables biológicas y de los biomarcadores inflamatorios tras un seguimiento de diez años
    Ignacio Gil Ortega · 2015
  64. Heart Failure and Metabolic Factors
    Peter M. Nilsson, John Molvin, Martin Magnusson · 2019 · Updates in hypertension and cardiovascular protection
  65. Diabetes y enfermedad cardiovascular, aspectos actuales de su manejo: la visión del cardiólogo
    Cristhian Felipe Ramirez-Ramos, Kelly Betancur-Salazar, Gustavo Adolfo Castilla-Agudelo, Santiago Carvalho Saldarriaga, Mateo Aranzazu-Uribe, Diego Alejandro Ramírez Méndez, Echeverria Cespedes, Jhon Fredy Salamanca Montilla, César López Martínez, Clara Saldarriaga · 2020 · Revista Colombiana de Endocrinología Diabetes & Metabolismo
  66. Low adherence to loop diuretic therapy as a trigger for decompensation in chronic heart failure
    Marta Isabel Rodrigues Casal Moura · 2015 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  67. Disease Prevention in Heart Failure
    Viorel G. Florea, Jay N. Cohn · 2020 · Elsevier eBooks
  68. Management of Type 2 Diabetes in Stage C Heart Failure with Reduced Ejection Fraction
    Anjali Agarwalla, Jadry Gruen, Carli J. Peters, Lauren E. Sinnenberg, ANJALI TIKU OWENS, Nosheen Reza · 2022 · Cardiac failure review
  69. Left Ventricular Diastolic Dysfunction and Silent Myocardial Ischemia amongst Asymptomatic Type 2 Diabetic Patients in Two Referral Hospitals in Cameroon
    Joshua Njimbuc Walinjom, Jérôme Boombhi, Martine Claude Etoa Etoga, Collins Ambe Chenwi, Emerentia Eho, Alain Ménanga, Samuel Kingué · 2022 · World Journal of Cardiovascular Diseases
  70. Embedding guidelines into clinical practice
    Judy Winter · 2023 · Practical Diabetes
  71. Heart Failure and Cardiac Dysfunction in Diabetes
    Maxwell Eyram Afari, Michael M. Givertz · 2023 · Contemporary cardiology
  72. Diabetes, prediabetes, and heart failure
    Giuseppe M.C. Rosano, Javed Butler, Petar M Seferovic, Jelena P. Seferović, Francesco Cosentino · 2023 · Oxford University Press eBooks
  73. Cardiovascular Diseases Related to Diabetes and Obesity, volume III
    Lu Cai, Ying Xin, Jamie Lynn Young, Mohanraj Rajesh · 2024 · Frontiers research topics
  74. Use of the biomarker score in determining the risk of heart failure in diabetics in Goma, North Kivu in the Democractic Republic of the Congo
    Ferdinand Ng’ekieb Mukoso, Aliocha Natuhoyila Nkodila, Hippolyte Nani Tuma Situakibanza, Stannislas Okitotsho Wembonyama, Zacharie Kibendelwa Tsongo · 2024 · International Journal of Cardiology Cardiovascular Risk and Prevention
  75. SGLT2 Inhibitors and Mechanism of Cardiovascular Benefits in Type 2 Diabetes
    Mukesh Nandave · 2024 · Springer eBooks
  76. Air pollution, temperature, and HbA1c levels among children in Mexico City, Mexico
    Jeanne Wu, Pablo Knobel, Mike Z. He, Itai Kloog, Allan C. Just, Iván Gutiérrez-Ávila, Elena Colicino, Martha María Téllez‐Rojo, María Luisa Pizano-Zárate, Marcela Tamayo‐Ortiz et al. · 2025 · Ecotoxicology and Environmental Safety
  77. Dysfunctional HDL-cholesterol: a potential link between high levels of HDL-cholesterol and cardiovascular disease?
    Peta Taylor · 2013 · Otago University Research Archive (University of Otago)
  78. Medical Treatment of Heart Failure and Coronary Heart Disease
    Roberta C. Bogaev, Deborah E. Meyers · 2015 · Cardiovascular medicine
  79. Additional file 1 of Association of fasting glucose with lifetime risk of incident heart failure: the Lifetime Risk Pooling Project
    Arjun Sinha, Hongyan Ning, Faraz S. Ahmad, Michael P. Bancks, Mercedes R. Carnethon, O’Brien, Matthew J., Allen, Norrina B., John T. Wilkins, Donald M Lloyd-Jones, Khan, Sadiya S. · 2021 · Figshare
  80. Epidemiology and Pathophysiology of Heart Failure With Preserved and With Reduced Ejection Fraction in Patients With Type 2 Diabetes
    David A. Aguilar · 2026 · Elsevier eBooks
  81. The Cardiovascular Continuum Between Hypertension, Diabetes and Cardiovascular Disease
    2026 · Frontiers research topics
  82. Interleukin‐19 Regulates Adipose Tissue Dysfunction in Obesity: Interplay Between Inflammation and Vascularization
    Christine N. Vrakas, Tatsuo Kawai, Mitali Ray, Allison B. Herman, Zeinab Etwebi, Sheri E. Kelemen, Rosario G. Scalia, Michael V. Autieri · 2026 · The FASEB Journal
  83. Association Between Time-Weighted Haemoglobin A1c and Longitudinal Changes in Growth Parameters Among Children With Type 1 Diabetes: A Retrospective Cohort Study
    Fadi Ayyash, Sondos Barjas Harahshih, Hadeel Othman Alqurieny, Asmaa Monther Al Quraan, Waed Mahmoud Itewi, Aseel F Nimri, Osama Al Fanek, Saif Batarseh, Abdelrazaq Ahmad Alyasin · 2026 · Cureus
  84. Type 2 Diabetes Mellitus and Impaired Glucose Regulation in a multi-ethnic population
    Samiul A Mostafa · 2014 · Leicester Research Archive (University of Leicester)